Reported 22 days ago
Eli Lilly, currently valued at around $830 billion, is anticipated to be the first healthcare company to break into the trillion-dollar market capitalization club. With a focus on GLP-1 weight loss drugs and Alzheimer's treatments, alongside a partnership with OpenAI to integrate AI in healthcare, Eli Lilly is positioned for significant growth and innovation in the medical field. As the demand for its products soars, especially in light of the obesity crisis and the expanding market for Alzheimer's treatments, its trajectory suggests a promising future as a leading player in the industry.
Source: YAHOO